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Abstract
 
Rationale and aims
 
Quality circles (QCs) are well established as a means of aiding
doctors. New quality improvement strategies include benchmarking activities. The aim of
this paper was to evaluate the efﬁcacy of QCs for asthma care working either with general
feedback or with an open benchmark.
 
Methods
 
Twelve QCs, involving 96 general practitioners, were organized in a randomized
controlled trial. Six worked with traditional anonymous feedback and six with an open
benchmark; both had guided discussion from a trained moderator. Forty-three primary care
practices agreed to give out questionnaires to patients to evaluate the efﬁcacy of QCs.
 
Results
 
A total of 256 patients participated in the survey, of whom 185 (72.3%) responded
to the follow-up 1 year later. Use of inhaled steroids at baseline was high (69%) and self-
management low (asthma education 27%, individual emergency plan 8%, and peak ﬂow
meter at home 21%). Guideline adherence in drug treatment increased (
 
P
 
 
 
=
 
 0.19), and
asthma steps improved (
 
P
 
 
 
=
 
  0.02). Delivery of individual emergency plans increased
(
 
P
 
 
 
=
 
  0.008), and unscheduled emergency visits decreased (
 
P
 
 
 
=
 
  0.064). There was no
change in asthma education and peak ﬂow meter usage. High medication guideline adher-
ence was associated with reduced emergency visits (OR 0.24; 95% CI 0.07–0.89). Use of
theophylline was associated with hospitalization (OR 7.1; 95% CI 1.5–34.3) and emer-
gency visits (OR 4.9; 95% CI 1.6–14.7). There was no difference between traditional and
benchmarking QCs.
 
Conclusions
 
Quality circles working with individualized feedback are effective at
improving asthma care. The trial may have been underpowered to detect speciﬁc bench-
marking effects. Further research is necessary to evaluate strategies for improving the self-
management of asthma patients.
 
Introduction
 
Asthma has a high prevalence as a chronic disease, affecting
nearly 5% of the population in industrialized nations [1]. It is a
comparatively cost-intensive illness because of chronic medica-
tion and frequent hospitalization accompanied by periods of dis-
ability. In Germany, total costs have been estimated at 
 
€
 
2.74
billion for 1999 [2]. The hallmarks of effective therapy to stabilize
the course of disease are optimal medication and self-manage-
ment. Medication is optimal when patients use inhaled steroids
[3], but this cannot be taken for granted, as not only patients [4] but
also doctors might have some aversion to steroids [5]. The optimal
self-management of patients comprises asthma education and
keeping an asthma diary, and the regular measurement of peak
expiratory ﬂow. These measures have been demonstrated to be
effective at reducing morbidity and mortality [6]. However, many
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patients seem to feel uncomfortable with regular monitoring of the
disease [4,7] and thus need to be repeatedly motivated for self-
management. Therefore, general practitioners (GPs) have a key
role in continuous support, as they have to provide comprehensive
medical care. This involves manifold duties and responsibilities,
such as organizing education, providing asthma diaries, disease
monitoring and medication control.
Quality circles (QCs) are well-established instruments for aid-
ing a doctor’s daily work by regular conjointly reﬂection on com-
mon practice with other colleagues [8]. However, one large trial
evaluating the group education of GPs identiﬁed only small
improvements in asthma and chronic obstructive pulmonary dis-
ease (COPD) care [9]. Another trial found peer-review groups
combined with individual feedback to be only slightly effective for
asthma care [10]. In QCs using individual feedback, prescribing
data are discussed in the group under the guidance of a moderator
without exchanging individual practice results [11]. New quality
improvement strategies include feedback with benchmark activi-
ties, where ‘best practice’ is openly labelled and discussed [12,13].
However, it is unclear whether the presentation of ‘achievable
benchmarks of care’ is effective for QCs. The aim of the trial was
to evaluate (a) the effectiveness of QCs using the individualized
feedback of prescribing data, and (b) the effectiveness of bench-
marking on asthma care, in particular on asthma severity as the
most patient-relevant outcome parameter. A secondary aim was to
evaluate the impact of medication guideline adherence on hospi-
talization and unscheduled emergency visits in primary care.
 
Methods
 
Study design
 
The study was designed as a two-armed randomized controlled
trial. One arm comprised a traditional QC without benchmark. The
second arm comprised a QC working with an open benchmark and
discussion of the results. After giving consent, the GPs were ran-
domized to the ‘traditional’ arm vs. the study arm working with
benchmarking. These GPs were grouped into a total of 12 QCs.
Six QCs worked with an open benchmark, and the other six
worked with the traditional discussion style. The study was
approved by the Medical Ethics Committee of the Medical Faculty
of the University of Heidelberg on 12 November 2004 (application
number 371/2004).
 
Traditional QCs
 
An individual feedback report about prescribing data from one’s
own practice is normally posted to each doctor a few days before
they meet in QCs, so that the report can be read before the meet-
ing. In the QCs, the doctors usually interpret their own data with-
out exchanging their individual practice results with one another.
The GPs also receive a feedback report with additional informa-
tion about the group performance of the other doctors. This allows
them to compare their own results with the variability of perfor-
mance (median, quartiles, minimum and maximum) of the other
doctors. The GPs discuss problems of care under the guidance of a
moderator, and the respective quality indicators serve as a basis for
discussion. In the present study, the GPs in traditional QCs also
received the baseline questionnaire results describing the number
of patients with an individual emergency plan, an asthma diary and
peak ﬂow meter at home. Using this information, the doctors
discussed the feasibility of a new set of asthma guidelines, the
management of asthma education or prescribing management. The
discussion was facilitated by comprehensive information on evi-
dence-based asthma therapy, including examples of individual
emergency plans and asthma diaries, and other indices of patient
management.
 
QCs with benchmarking
 
The basic structure is identical to that of traditional QCs: individ-
ual feedback reports were given to the participating GPs in these
QCs, but with a comparison with a performance ‘benchmark’.
These GPs received the name of and information about the GP
who performed best in their QCs and information about the perfor-
mance of the ‘best 10%’ of GPs in the benchmark arm. Under the
guidance of the moderator, the GPs discussed with the identiﬁed
GP how the best practice was achieved. In addition, practice
details of the ‘overall best practice’ of the benchmarking arm were
given to enable a comparison with the best benchmark. This mul-
tifaceted benchmark intervention was intended to allow learning
from the best performer. The moderators of both arms were trained
before the QC meetings to lead the group discussion.
 
Setting and patients
 
At the beginning of this study, 97 GPs in 87 general practices
collaborating in this project were asked to participate in the survey.
As the workload in these practices was particularly high because
of the implementation of a new fee-for-service structure during the
study period, only 42 practices agreed on handing out the ques-
tionnaires (27 in the benchmarking group and 15 in the traditional
group). The GPs were instructed in a leaﬂet to select patients with
asthma as accurately as possible. The most relevant criteria to
distinguish between asthma and COPD were explained in this
leaﬂet. For example, the GPs were instructed to preferably select
patients with varying symptoms, attacks of dyspnoea and wheez-
ing, or with a known allergy. They were to avoid including heavy
smokers, who were likely to have COPD.
The GPs were asked to hand out a questionnaire consecutively
to every asthma patient coming for consultation between May and
July 2005 (T1). The patients were asked to ﬁll in the questionnaire
and to send it to the study centre, receiving assurances of the
anonymous handling of their data. Three lots of 
 
€
 
250 were rafﬂed
as an incentive for participation. One year later (T2), the patients
received the same questionnaire directly from the study centre.
Again, three lots of 
 
€
 
250 were rafﬂed as an incentive. Three
reminders were sent out after 4, 8 and 12 weeks.
 
Measures
 
Routine prescribing data as primary outcome measures are yet to
be made available by the compulsory health insurance organization
Allgemeine Ortskrankenkasse (AOK). However, these data will be
obtained after careful control and anonymizing in February 2007
at the earliest. The secondary outcome measures were evaluated
using the questionnaire.
The patients were asked about their daily and nocturnal symp-
toms related to asthma, according to the international levels of 
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asthma severity steps 1 to 4 [14]. Current medication, including
dosage, was documented in a structured register. Furthermore, the
patients were questioned on various aspects of self-management.
Speciﬁcally, we wanted to know whether a patient (a) had already
participated in an education programme on asthma; (b) wanted to
receive education; (c) had a peak ﬂow meter at home; (d) used a
peak ﬂow meter regularly to monitor the disease; (e) had a per-
sonal emergency plan; (f) had been admitted to hospital within the
last 12 months because of asthma; and (g) had received unsched-
uled home visits from a GP or ambulatory care due to asthma
within the last 12 months.
 
Analysis
 
The questionnaires were scanned and the data were imported
automatically into 
 
SPSS
 
 14.0. by Eyes & Hands
 
®
 
 Forms, Version 5
(ReadSoft AB, Sollentuna, Sweden). The plausibility of the data
was checked manually, and baseline data were presented descrip-
tively. Differences between men and women, and responders and
non-responders were calculated with 
 
t
 
-tests or 
 
χ
 
2
 
-tests where
appropriate.
To assess adherence to guidelines, the medication was checked
manually for each patient. Full adherence to guidelines implied
that the prescribed medication was consistent with the guidelines
[14] and that the patient was in asthma step 1 or 2 for day and
night. Guideline adherence but under-dosing of medication
implied that the patient received appropriate medication, such as
inhaled steroids, but rated him/herself as being in asthma step 3 or
4 for day or night so that the dose could be increased. Inappropri-
ate prescribing of medication implied that the patient had not been
treated according to guidelines, for example if only sympathomi-
metics were given without steroids in step 2, 3 or 4.
Before–after differences of guideline adherence and asthma
steps were calculated using the McNemar test, a non-parametric
test for dependent samples. Predictive values related to hospital-
ization and unscheduled emergency visits were estimated using
univariate logistic regression.
 
Results
 
Baseline characteristics and follow-up
 
A total of 314 patients, of whom 159 (62.5%) were female,
received the questionnaire; the average age was 56.8 years. Two
hundred and ﬁfty-six (81.5%) patients sent back the questionnaire.
Of the responders, 158 (61.7%) were female, and the average age
was 56.3  years. There was no signiﬁcant difference between
responders and non-responders with regard to sex and age at
baseline (data not shown). Nearly half of the patients reported
symptoms corresponding to asthma step 3 or 4 (Table 1). The use
of steroids was comparatively high, with 68.8% receiving inhaled
and 8.2% oral steroids. Only 27% had previously participated in
an asthma programme. The extent of self-management was low, as
only 21.1% had a peak ﬂow meter at home, only 4.3% used an
asthma diary, and 8.2% had an individual emergency plan.
One hundred and eighty-ﬁve patients (72.3%) responded to the
follow-up 1 year later. Seventy-one were unable to be included at
follow-up. Of these patients, 11 had an unknown address and one
patient had died. There was no signiﬁcant difference in sex, age
and self-management between responders and non-responders at
follow-up.
 
Effects on asthma severity and medication 
guideline adherence
 
Clinical improvement was operationalized as change in asthma
severity (Table  2). The number of patients with asthma step 3
 
Table 1
 
Baseline characteristics at baseline (
 
n
 
 
 
=
 
 256)
Number of
patients (%)
Asthma step at day
1 Symptoms less than once a week 59 (23.3)
2 Symptoms more than once a week but less than 
once a day
63 (24.6)
3 Symptoms daily, but not continuously 92 (35.9)
4 Symptoms continuously with limitation to physical 
activities
19 (7.4)
Medication
Inhaled sympathomimetics 200 (78.1)
Inhaled steroids 176 (68.8)
Oral steroids 21 (8.2)
Theophylline 85 (33.2)
Montelukast 17 (6.6)
Self-management
Asthma education 69 (27.0)
Peak ﬂow meter at home 54 (21.1)
Use of asthma diary 11 (4.3)
Individual emergency plan 21 (8.2)
Smoking 65 (25.4)
 
Table 2
 
Changing in asthma steps (before–after comparison)
Asthma step
Traditional
(T1 and T2 complete)
Benchmark 
(T1 and T2 complete)
 
P
 
 (McNemar) Non-responder at T2 T1 T2 T1 T2
Step 1 (best) 15 (24.2%) 15 (23.8%) 31 (27.7%) 13 (22.0%)  0.097 13 (22.0%)
Step 2 16 (25.8%) 20 (31.7%) 24 (21.4%) 23 (39.0%)
 
0.055
 
23 (39.0%)
Step 3 27 (43.5%) 21 (33.3%) 46 (41.1%) 19 (32.2%)
 
0.046
 
19 (32.2%)
Step 4 (worst) 4 (6.5%) 7 (11.1%) 11 (9.8%) 4 (6.8%) 0.541 4 (6.8%)
Total 62 63 112 59 59
T1 
 
=
 
 baseline; T2 
 
=
 
 follow-up 12 months later. Bold values indicate signiﬁcant results. 
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decreased (
 
P
 
 
 
=
 
 0.046) and patients with asthma step 2 increased
(
 
P
 
 
 
=
 
  0.055). The non-responders at follow-up seemed to be
slightly healthier, as they had more favourable asthma steps;
indeed the difference was not signiﬁcant (
 
P
 
 
 
=
 
 0.124; 
 
χ
 
2
 
-test; data
not shown). As an overall effect, the change from the unfavourable
group (asthma steps 3 and 4) into the beneﬁcial group (asthma
steps 1 and 2) was signiﬁcant (
 
P
 
 
 
=
 
 0.018). There was no group
difference between benchmarking and traditional QCs in all of
these categories.
The improvement in asthma severity is slightly reﬂected in the
improvement of asthma therapy. There was a trend towards an
increase of full adherence to guidelines and decrease of under-
dosing (Table 3). However, these effects were not signiﬁcant.
 
Self-management, hospital stay and 
unscheduled visits
 
There was no change in asthma education, peak ﬂow meter at
home and use of asthma diary (Table 4). The number of patients
with an individual emergency plan increased (
 
P
 
 
 
=
 
 0.008), although
this number remains low. There was a decrease in the number of
patients with unscheduled emergency visits (
 
P
 
 
 
=
 
  0.064) and a
decrease in the number of visits (
 
P
 
 
 
=
 
 0.096). Also, in these catego-
ries, there was no group difference between benchmarking and
traditional QCs.
 
Predictors of emergency visits and 
hospitalization
 
The risk for hospitalization and unscheduled emergency visits
over 1 year increased signiﬁcantly with asthma severity (Table 5).
The number of patients with unscheduled emergency visits
decreased signiﬁcantly with guideline adherence (‘Guideline
adherence’ comprised patients with ‘full adherence to guidelines’
and ‘guideline adherence, end-of-dose’.) The use of theophylline
predicted hospitalization and unscheduled visits. An additional
logistic regression, including interaction analysis, showed a mar-
ginal but non-signiﬁcant interaction between asthma severity and
 
Table 3
 
Guideline adherence with therapy (before–after comparison)
Guideline
adherence
Traditional quality circle 
(
 
n
 
 
 
=
 
 62)
Benchmark quality circle 
(
 
n
 
 
 
=
 
 113)
 
P
 
 (McNemar) T1 T2 T1 T2
Full adherence to guidelines 21 (33.9%) 26 (41.9%) 45 (40.2%) 49 (43.4%) 0.188
Full adherence to guideline, end-of-dose 6 (9.7%) 4 (6.5%) 8 (7.1%) 8 (7.1%) 0.791
Guideline adherence, but dose too low 23 (37.1%) 18 (29.0%) 38 (33.9%) 32 (28.3%) 0.268
No guideline adherence, patient in step 1 or 2 7 (11.3%) 6 (9.7%) 7 (6.3%) 9 (8.0%) 1.000
No guideline adherence, patient in step 3 or 4 5 (8.1%) 8 (12.9%) 14 (12.5%) 15 (13.3%) 1.000
T1 
 
=
 
 baseline; T2 
 
=
 
 follow-up 12 months later.
 
Table 4
 
Changes in self-management, hospital stays and unscheduled visits (before–after comparison)
Management aspects
Traditional quality circle 
(
 
n
 
 
 
=
 
 62)
Benchmark quality circle 
(
 
n
 
 
 
=
 
 113)
 
P
 
 (McNemar) T1 T2 T1 T2
Asthma education 20 (30.3%) 20 (30.3%) 37 (31.1%) 39 (32.8%) 0.584
Peak ﬂow at home 16 (24.2%) 20 (30.3%) 27 (22.7%) 27 (22.7%) 0.424
Asthma diary 5 (7.6%) 6 (9.1%) 3 (2.5%) 6 (5.0%) 0.289
Emergency plan 4 (6.1%) 7 (10.6%) 8 (6.7%) 17 (14.3%)
 
0.008
 
Hospital stay 5 (7.6%) 3 (4.5%) 9 (7.6%) 7 (5.9%) 0.727
Emergency visits 13 (19.7%) 4 (6.1%) 21 (17.6%) 13 (10.9%)
 
0.064
 
Number of unscheduled visits 14 20 51 20
 
0.096
 
T1 
 
=
 
 baseline; T2 
 
=
 
 follow-up 12 months later. Bold values indicate signiﬁcant results.
 
Table 5
 
Predictors of unscheduled emergency visits and hospitalization within following 12 months (logistic regression)
Predictor (T1)
Hospital stay (Yes/No) (T2) Emergency visit (Yes/No) (T2)
OR 95% CI
 
P
 
OR 95% CI
 
P
 
Asthma step 2.56 1.07–6.16
 
0.035
 
3.51 1.63–0.752
 
0.001
 
Guideline adherence (yes/no) 0.562 0.14–2.33 0.426 0.24 0.07–0.89
 
0.033
 
Using sympathomimetics 2.03 0.25–16.64 0.509 3.07 0.47–29.10 0.213
Using inhaled steroids 1.48 0.30–7.24 0.629 1.19 0.37–3.87 0.769
Using oral steroids 2.16 0.75–6.20 0.152 0.98 0.27–3.58 0.975
Using theophylline 7.1 1.5–34.3
 
0.016
 
4.9 1.6–14.7
 
0.005
 
T1 
 
=
 
 baseline; T2 
 
=
 
 follow-up 12 months later. Bold values indicate signiﬁcant results. 
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the use of theophylline with regard to emergency visits (OR for
interaction 0.18; 95% CI 0.03–1.30; 
 
P
 
 
 
=
 
 0.09).
 
Discussion
 
The results of our trial indicate that QCs can be effective at
improving outcomes for patients with asthma. While asthma steps
improved signiﬁcantly, which is slightly reﬂected in the improve-
ment of drug treatment, few changes in clinical management were
identiﬁed. Unscheduled emergency visits decreased, which might
be associated with the effect on asthma severity. However, it was
not possible with this randomized trial to demonstrate the superi-
ority of using an open benchmark in QCs.
Nearly 70% of patients received inhaled steroids and 8.2% had
oral steroids. This is a high level of inhaled steroid usage com-
pared with a huge European survey in which only 23% used
inhaled steroids regularly [15]. The quality of medical treatment
improved after the QC sessions as full adherence to guidelines
increased and under-dosing decreased after 12 months. This effect
was not signiﬁcant, but it is possibly reﬂected by the signiﬁcant
clinical improvement in patients. In contrast to a postulated under-
use of steroids [15,16], our results suggest a comparatively satisfy-
ing level of steroid use. It might be overambitious or even inade-
quate to achieve the goals set by the guidelines, which are reached
by consensus [17], in every patient. However, medication with
guideline adherence is of importance, as our results illustrate.
Patients with optimal medication at baseline had signiﬁcantly
lower emergency visits within the following year.
The association between use of theophylline, hospital stay and
emergency visits remains to be discussed. On the one hand, this
could indicate low guideline adherence in terms of prescribing,
accompanied by under-use of inhaled steroids, which are vital to
efﬁcient asthma therapy [1] as they reduce morbidity and mortality
[3]. On the other hand, it cannot be excluded that theophylline
itself is responsible for emergency cases by way of insufﬁcient
suppression of eosinophilic inﬂammation or by causing serious
adverse effects due to its high potential for side effects [18].
Further evaluation would be necessary with larger sample sizes, as
the amount of hospitalization is low, thus leading to large conﬁ-
dence intervals and difﬁculties in adjusting for asthma severity.
Another critical point is the low number of patients receiving
education and support for self-management. The relevance of
these measures for reducing disability and hospitalization has been
demonstrated in several studies [6]. Meng 
 
et al
 
. also found a low
usage of peak ﬂow meter and therefore suggested the dissemina-
tion of guidelines to patients themselves [19]. However, two-thirds
of the patients in our trial did not want to participate in asthma
education, irrespective of asthma severity [7]. Therefore, it
remains a challenge for GPs to motivate these patients to partici-
pate in asthma education in order to prevent a severe deterioration
of the disease. With the exception of the delivery of individual
emergency plans, there was no remarkable improvement in these
aspects.
However, all these measures together seemed to improve the
health outcomes in terms of asthma severity and unscheduled
emergency cases. This contrasts with the results of Smeele 
 
et al
 
.,
who found group education not effective [9]. One reason for this
difference could be that Smeele 
 
et al.
 
 included patients with asthma
and COPD, following the ‘Dutch hypothesis’, which presumes a
common aetiological factor in both diseases [20]. Newer develop-
ments aim to distinguish between these patients, and COPD
patients are more difﬁcult to treat because of nicotine dependency
and lack of medication to inﬂuence the decline of lung function
[21]. Therefore, it seems likely that improvement of care is more
difﬁcult to measure with changes in COPD patients. This could be
the same difﬁculty in the trial carried out by Jans 
 
et al.
 
, who tried
to detect improvement of peak ﬂow variability in asthma and
COPD patients by improving care with a multifaceted intervention,
including educational meetings [22]. Supporting our ﬁndings,
Lagerlov 
 
et al.
 
 tried to distinguish asthma from COPD and found
a signiﬁcant increase of acceptably treated asthma cases after peer-
review meetings combined with feedback of prescribing data [10].
Quality circles working with structured feedback have already
been shown to improve rational prescribing in general practice
[11]. The core element of these circles is the conjoint discussion of
evidence-based pharmacotherapy and management of patients on
the basis of prescribing data, under the guidance of a trained
moderator. Because of the paradigm of ‘multifaceted intervention’
[23], these QCs are facilitated with an individual feedback report
of prescribing data from each doctor’s own practice compared
with average data from the QC and from the whole study arm. It
remains unclear whether the presentation of ‘best practice of the
QC’ and the ‘best 10% of the study arm’ as an achievable bench-
mark of care can lead to further improvement above the ‘tradi-
tional’ means of feedback. One reason for this is that fewer
patients participated in the questionnaire survey than initially
expected. Therefore, our trial might be too underpowered to detect
a speciﬁc benchmarking effect. On the other hand, it needs to be
taken into account that the traditional feedback report also con-
tains benchmark elements, as one’s own practice is compared with
certain parameters (median, quartiles, minimum and maximum)
from the other GPs in the study arm.
The small increase in self-management behaviours reveals the
limitation of QCs. It seems unlikely that more sophisticated per-
formance of QCs would be able to solve this problem, in particular
as this kind of patient management is strongly dependent on orga-
nization within the practice team. As there is still no ‘magic bullet’
[24] in quality improvement, it seems more promising to amplify
the multifaceted intervention [23]. Further trials have to show
whether accessory outreach visits or academic detailing [25], ide-
ally with the inclusion of the whole practice team, is able to
improve these deﬁcits.
Our trial has some limitations. Most important is that only 43
out of 96 practices agreed to distribute the questionnaires because
of a high workload due to the implementation of a new fee-for-
service structure during the study period. This could have led to a
selection of highly motivated GPs and therefore an overestimation
of the effectiveness of the QCs. Another critical point is that not all
patients responded at follow-up. However, more than 70% did, and
the non-responding patients seemed to be slightly healthier. This
could also have led to some overestimation of the effectiveness.
On the other hand, this underscores the high potential of QCs, as it
may have been the more difﬁcult patients who participated.
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